COMMON EQUITY (Tables)

6 Months Ended

Jun. 30, 2024

Equity [Abstract]

Schedule of stock-based compensation awards granted

During the six months ended June 30, 2024, the Compensation Committee of our Board of Directors awarded the following stock-based compensation to our directors, officers, and certain other key employees:

Award Type	Number of Awards
Stock options (1)	294,990
Restricted shares (2)	108,484
Performance units	205,051

(1)Stock options awarded had a weighted-average exercise price of $84.92 and a weighted-average grant date fair value of $16.19 per option.

(2)Restricted shares awarded had a weighted-average grant date fair value of $84.97 per share.

Schedule of Common Stock Outstanding Roll Forward

We had the following changes to our outstanding common stock during the three and six months ended June 30, 2024:

	Three Months Ended June 30, 2024	Six Months Ended June 30, 2024
Common stock shares outstanding at beginning of period	315,822,587	315,434,531
Shares issued:
Stock-based compensation	20,488	162,666
401(k)	122,300	246,600
Stock investment plan	114,026	235,604
Common stock shares outstanding at end of period	316,079,401	316,079,401